Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency

Melissa Robinson1, Matthew Greenhawt2, David R Stukus3

  • 1Section of Allergy and Immunology, National Jewish Hospital, Denver, Colorado.

Insights

Epinephrine, the primary treatment for anaphylaxis, is underused in prehospital settings. Factors like reaction location and severity influence its timely administration in children, necessitating increased awareness and education.

Area of Science:

  • Pediatric Emergency Medicine
  • Allergy and Immunology
  • Public Health

Background:

  • Epinephrine is the recommended first-line treatment for anaphylaxis.
  • Underuse of epinephrine by patients and medical personnel is a concern.

Purpose of the Study:

  • To identify factors influencing anaphylaxis management before emergency department (ED) or urgent care center (UCC) arrival.
  • To evaluate the timeliness and patterns of prehospital epinephrine administration in pediatric patients.

Main Methods:

  • Retrospective review of electronic medical records for patients aged 0-25 years presenting with anaphylaxis.
  • Analysis of 408 patient records from 2009-2013 at a pediatric academic referral center.

Main Results:

  • Only 36.3% of patients received epinephrine before ED/UCC arrival.
  • Reactions at home were less likely to be treated with epinephrine compared to school reactions.
  • Lower odds of prehospital epinephrine use were associated with multi-organ system involvement and home-based reactions.

Conclusions:

  • Significant delays in epinephrine administration for pediatric anaphylaxis were observed.
  • Increased awareness and education for caregivers, patients, and medical professionals are crucial for optimal anaphylaxis management.
  • Factors such as reaction location and severity impact prehospital epinephrine use.
Abstract

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
32.7K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
76
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
2.1K
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.0K
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Adrenergic Agonists: Mixed-Action Agents01:28

Adrenergic Agonists: Mixed-Action Agents

Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.6K